Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 1 56-1, 2004, Pages

  Cao, Chunhua ^a   Kang, Chang Won ^b   Kim, Sung Zoo ^a   Kim, Suhn Hee ^a,c  

^a Chonbuk National University   (South Korea)

^b Chonbuk National University   (South Korea)

^c Chonbuk National University Medical School   (South Korea)

Author keywords

Adrenoceptor; Contractility; Hypertension; Imidazoline

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATRIAL NATRIURETIC FACTOR; CLONIDINE; EFAROXAN; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE I1 RECEPTOR AGONIST; IMIDAZOLINE I1 RECEPTOR ANTAGONIST; IMIDAZOLINE RECEPTOR; MOXONIDINE; RAUWOLSCINE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG PROTEIN BINDING; HEART; HEART ATRIUM ENLARGEMENT; HEART FAILURE; HYPERTENSION; ISOLATION PROCEDURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; PULSE PRESSURE; RAT; REGULATORY MECHANISM; RENOVASCULAR HYPERTENSION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ATRIAL FUNCTION; ATRIAL NATRIURETIC FACTOR; BENZOFURANS; BLOOD PRESSURE; CARDIOMEGALY; CLONIDINE; HEART ATRIA; HEMODYNAMIC PROCESSES; IMIDAZOLES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG; YOHIMBINE;

EID: 3042577499     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00977.2003     Document Type: Article

References (29)

1. Bousquet P, Feldman J, and Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther 230: 232-236, 1984.
2. Bricca G, Dontenwill M, Molines A, Feldman J, Belcourt A, and Bousquet P. The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. Eur J Pharmacol 162: 1-9, 1989.
3. Brown CM, Mackinnon AC, McGrath JC, Spedding M, and Kilpatrick AT. alpha 2-Adrenoceptor subtypes and imidazoline-like binding sites in the rat brain. Br J Pharmacol 99: 803-809, 1990.
4. Cho KW, Kim SH, Hwang YH, and Seul KH. Extracellular fluid translocation in perfused rabbit atria: implication in control of atrial natriuretic peptide secretion. J Physiol 468: 591-607, 1993.
5. Cho KW, Seul KH, Kim SH, Koh GY, Seul KM, and Hwang YH. Sequential mechanism of atrial natriuretic peptide secretion in isolated perfused rabbit atria. Biochem Biophys Res Commun 172: 423-431, 1990.
6. Cho KW, Seul KH, Kim SH, Seul KM, and Koh GY. Atrial pressure, distension, and pacing frequency in ANP secretion in isolated perfused rabbit atria. Am J Physiol Regul Integr Comp Physiol 260: R39-R46, 1991.
7. Cho KW, Seul KH, Kim SH, Seul KM, Ryu H, and Koh GY. Reduction volume dependence of immunoreactive atrial natriuretic peptide secretion in isolated perfused rabbit atria. J Hypertens 7: 371-375, 1989.
8. Dontenwill M, Tibirica E, Greney H, Bennai F, Feldman J, Stutzman J, Bricca G, Belcourt A, and Bousquet P. Role of imidazoline receptors in cardiovascular regulation. Am J Cardiol 74: 3A-6A, 1994.
9. El-Ayoubi R, Gutkowska J, Regunathan S, and Mukaddam-Daher S. Imidazoline receptors in the heart: characterization, distribution, and regulation. J Cardiovasc Pharmacol 39: 875-883, 2002.
10. Gutkowska J, Mukaddam-Daher S, and Tremblay J. The peripheral action of clonidine analog ST-91: involvement of atrial natriuretic factor. J Pharmacol Exp Ther 281: 670-676, 1997.
11. Han JH, Cao C, Kim SC, Cho KW, and Kim SH. Decreases in ANP secretion by lysophosphatidylcholine through protein kinase C. Hypertension 41: 1380-1385, 2003.
12. 1-imidazoline receptors in the rostral ventrolateral medulla. J Cardiovasc Pharmacol 24 SupplI: s1-s8, 1994.
13. Kobinger W. Central alpha-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 81: 39-100, 1978.
14. Li P, Penner SB, and Smyth DD. Attenuated renal response to moxonidine and rilmenidine in one kidney-one clip hypertensive rats. Br J Pharmacol 112: 200-206, 1994.
15. Messerli F. Moxonidine: a new and versatile antihypertensive. J Cardiovasc Pharmacol 35 Suppl 4: s53-s56, 2000.
16. Mukaddam-Daher S and Gutkowska J. Atrial natriuretic peptide is involved in renal actions of moxonidine. Hypertension 35: 1215-1220, 2000.
17. Mukaddam-Daher S and Gutkowska J. The renal actions of moxonidine are mediated by atrial natriuretic peptide and involve the opioid receptors. Ann NY Acad Sci 881: 385-387, 1999.
18. Mukaddam-Daher S, Lambert C, and Gutkowska J. Clonidine and ST-91 may activate imidazoline binding sites in the heart to release atrial natriuretic peptide. Hypertension 30: 83-87, 1997.
19. Ohara-Imaizumi M and Kumakura K. Effects of imidazoline compounds on catecholamine release in adrenal chromaffin cells. Cell Mol Neurobiol 12: 273-283, 1992.
20. 1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience. J Cardiovasc Pharmacol 24 Suppl 1: s39-s48, 1994.
21. Piletz JE, Halaris A, Nelson J, Qu Y, and Bari M. Platelet Itimidazoline binding sites are elevated in depression but not generalized anxiety disorder. J Psychiatr Res 30: 147-168, 1996.
22. 2a- adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy. Biol Psychiatry 48: 932-939, 2000.
23. Prichard BN, Graham BR, and Owens CW. Moxonidine: a new antiadrenergic antihypertensive agent. J Hypertens 17 Suppl 3: s41-s54, 1999.
24. Regunathan S, Feinstein DL, and Reis DJ. Expression of non-adrenergic imidazoline sites in rat cerebral cortical astrocytes. J Neurosci Res 34: 681-688, 1993.
25. 3 receptors. Neurochem Int 30: 73-83, 1997.
26. Smyth DD and Penner SB. Peripheral and central imidazoline receptor-mediated natriuresis in the rat. Ann NY Acad Sci 881: 344-357, 1999.
27. Tibirica E, Mermet C, Feldman J, Gonon F, and Bousquet P. Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach. J Pharmacol Exp Ther 250: 642-647, 1989.
28. 1-imidazoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertensives. Hypertension 32: 1022-1027, 1998.
29. 3H]idazoxan in the rabbit urethral smooth muscle. Pharmacological and biochemical characterization. Biochem Pharmacol 41: 701-707, 1991.